Fostering a truly inclusive society hinges on freedom for everyone, including individuals living with rare diseases. Every person, regardless of their health challenges, deserves the opportunity to live an independent, dignified life with access to the resources they need. 🌐 In the latest episode of the #SMAMyWay podcast, we explore how we can create tangible change for those living with rare diseases like Spinal Muscular Atrophy (#SMA). 🤝 Tune in, engage, and be part of the movement advocating for a more inclusive world. http://spkl.io/604947hY5
Info
Roche ist ein globales Unternehmen mit Vorreiterrolle in der Erforschung und Entwicklung von Medikamenten und Diagnostika und ist darauf fokussiert, Menschen durch wissenschaftlichen Fortschritt ein besseres, längeres Leben zu ermöglichen. Dank der Kombination von Pharma und Diagnostika unter einem Dach ist Roche führend in der personalisierten Medizin - einer Strategie mit dem Ziel, jeder Patientin und jedem Patienten die bestmögliche Behandlung zukommen zu lassen. Roche ist das grösste Biotech-Unternehmen weltweit mit differenzierten Medikamenten für die Onkologie, Immunologie, Infektionskrankheiten, Augenheilkunde und Erkrankungen des Zentralnervensystems. Roche ist auch der bedeutendste Anbieter von In-vitro-Diagnostika und gewebebasierten Krebstests und ein Pionier im Diabetesmanagement. Seit der Gründung im Jahr 1896 erforscht Roche bessere Wege, um Krankheiten zu verhindern, zu erkennen und zu behandeln und leistet einen nachhaltigen Beitrag zur gesellschaftlichen Entwicklung. Zum Ziel des Unternehmens gehört es durch Kooperationen mit allen relevanten Partnern den Zugang von Patienten zu medizinischen Innovationen zu verbessern. Auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation stehen heute 30 von Roche entwickelte Medikamente, darunter lebensrettende Antibiotika, Malariamittel und Krebsmedikamente. Ausgezeichnet wurde Roche zudem bereits das neunte Jahr in Folge als das nachhaltigste Unternehmen innerhalb der Pharma-, Biotechnologie- und Life-Sciences-Branche im Dow Jones Sustainability Index. Die Roche-Gruppe mit Hauptsitz in Basel, Schweiz ist in über 100 Ländern tätig und beschäftigte 2017 weltweit rund 94 000 Mitarbeiterinnen und Mitarbeiter. Im Jahr 2017 investierte Roche CHF 10,4 Milliarden in Forschung und Entwicklung und erzielte einen Umsatz von CHF 53,3 Milliarden. Genentech in den USA gehört vollständig zur Roche-Gruppe. Roche ist Mehrheitsaktionär von Chugai Pharmaceutical, Japan. Weitere Informationen finden Sie unter www.roche.com/careers #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Website
-
http://www.roche.com/
Externer Link zu Roche
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Switzerland 🇨🇭
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data und Science
Orte
Beschäftigte von Roche
Updates
-
At Roche, our sustainability efforts are fundamental to our business and culture. 🌱 We prioritize reducing environmental impact 🌿, fostering innovation in healthcare, and promoting ethical practices across our global operations. By embedding environmental, social, and governance criteria in our strategies, we aim to create lasting value for our stakeholders and contribute to a sustainable future. 🌍 Join us in making a positive impact ⤵️ https://lnkd.in/ejWKKFi4 & Learn more about our comprehensive approach and commitment to making a positive difference. ⤵️ https://lnkd.in/gcxKmYhV
-
-
✨ The landscape of cancer care is evolving rapidly, with innovations continually entering the market to provide people with more flexible ways to receive care. 🌐 Jose Vicente Cardona, Director of Oncology Medical Affairs at Roche, discusses how some countries are able to integrate these innovations and lead the way towards cancer care that is closer to home. 👇 Read the full article by clicking the link in the comments. #cancer #innovation #healthcare
-
-
Early scientific advice from regulators is crucial to the long haul process of developing medicines. It saves precious time and costs for each of industry, health systems, and patients when we get early input on the science and design of clinical studies. For the current drive towards regulatory simplification in Europe to be effective, it will need for each of the relevant disciplines and decision bodies to be included. #EU Pharma Legislation. #SixBoldActions
-
🧩 Do you know, what is one of the key pieces in our global puzzle? It’s collaboration. It’s the way we fit our unique perspectives together to create a complete picture of innovation and progress.That's how we ensure every talent finds their place, contributing to breakthroughs in healthcare, improving the lives of patients all around the world. 🌍 At Roche, we believe that collaboration is like a puzzle: each piece is essential to the bigger picture. 🌟 Learn more about how we make an impact together: https://lnkd.in/ekfGnk6x
-
-
Roche hat dies direkt geteilt
Globally, the number of people diagnosed and living with brain disorders continues to rise. But what is not so evident is the financial and social cost to families and economies. In 2019, $1.2 trillion was lost in income by people living with brain disorders and $1.1 trillion was spent directly on care for brain disorders by households and payers. We are calling for change to address the burden of compromised #BrainHealth and look forward to hearing more at this year’s European Academy of Neurology Find out more in the following video Mikele Epperly Global Integrated Programme Leader, Brain Health. #EAN2024
-
Starting #cancer treatment for the first time is a daunting experience for patients and their loved ones. Nurses like Alba play a crucial role in ensuring their patients feel as relaxed as possible, helping them feel comfortable with their treatment administration. Learn more here: http://spkl.io/604447VZa
-
Globally, the number of people diagnosed and living with brain disorders continues to rise. But what is not so evident is the financial and social cost to families and economies. In 2019, $1.2 trillion was lost in income by people living with brain disorders and $1.1 trillion was spent directly on care for brain disorders by households and payers. We are calling for change to address the burden of compromised #BrainHealth and look forward to hearing more at this year’s European Academy of Neurology Find out more in the following video Mikele Epperly Global Integrated Programme Leader, Brain Health. #EAN2024
-
Transforming cancer care across Europe was the focus of the ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies hosted by the Institute of Oncology in Romania This event brought together representatives from all #EU member states and the European Commission, including public healthcare authorities, academia, and patient associations. The discussions centered on translating the Plan’s goals into actionable strategies at regional and local levels. With cancer cases expected to rise by 24% by 2035, making it the leading cause of death in the EU, addressing this challenge is more critical than ever. Representing #Roche, Michael Oberreiter emphasized our unique position to integrate best practices in oncology across Europe. Find more information here 👉 http://spkl.io/604747Kxf #innovation #digitalization
-
-
At Roche we strive to promote a global environment of equality where every employee around the world feels comfortable bringing their true and authentic selves to work. ✨🦄 During this #pride 🏳️🌈 month, we encourage everyone to discover the power of being an #ally in diversity and to add unique perspectives that foster innovative solutions for doing now what patients need next. Our organisation collaborates within a Roche Global Out, Proud & Equal Network, dedicated to connect all Roche OPEN chapters worldwide. ✅Learn more about diversity at Roche: go.roche.com/rochepride_li #RochePride #LGBTQSupport #RocheDiversity
-
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Letzte Runde
Kapitalerhöhung nach Börsengang5.000.000.000,00 $
Investor:innen